Form 4: Edwards Lifesciences Executive Wayne Markowitz Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Wayne Markowitz, GM & SVP, Surgical at Edwards Lifesciences, reports a disposition of 648 shares of common stock to cover tax obligations.
Summary
- On September 14, 2024, Wayne Markowitz, GM & SVP, Surgical at Edwards Lifesciences, reported a change in beneficial ownership of the company's common stock.
- A total of 648 shares were disposed of at a price of $68.52 per share.
- Following the transaction, Markowitz directly owns 10,033.0463 shares of Edwards Lifesciences common stock.
- The transaction was related to tax obligations.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to insider stock transactions and has a neutral sentiment.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders as it is a routine sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 09/14/2024 | Date of the stock transaction (disposal of shares) |
| 09/16/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.